This division conducts research on nanomaterials for health (nanoparticles for drug targeting, nanostructured implants), nanobiosensors and diagnostics (biomarker detection, physiological monitoring), nanomedicine and therapeutic vectorization (targeted drug delivery, gene therapies), fluid-nanostructure interactions for biotechnology applications, and modeling and simulation in nanomedicine to predict nanomaterial behavior in biological systems.